CRISPR

How Plant Sciences Will Feed 10 Billion People By 2050

Regular readers know that we don’t just publish articles, but foster a conversation about emerging technologies and how they will improve the world (and our investment portfolio). One of our ongoing themes – aside from Elon Musk’s hair – is how this little green and blue ball we inhabit can continue to sustain life as […]

6 CRISPR Applications from Healthcare Startups

One question we’re often asked at Nanalyze is what emerging technology do we think will be most disruptive in the long term. The short answer: All of them. Otherwise, we wouldn’t be devoting long hours at the laptop between trips to the local dispensary writing about all of this amazing progress. Artificial intelligence, as we’ve […]

A Few Updates on the Progress of Gene Editing

Whenever an exciting technology comes along, people want to invest in it. Even if those people have never put a single red penny into the stock market, they will suddenly start buying stocks with no regard towards the basic principles of prudent investing like diversifying your holdings and not investing in over-the-counter (OTC) stocks. To […]

Synthego and Synthetic Guide RNA Explained

Nobody could have possibly predicted what we all recently witnessed in awe. Some people reacted with hope and optimism, others with fear. Could things really have gotten to this point? Could anybody have predicted that society would be in the situation that it sits today? That a giant orange blob would be the focal point of nations around […]

Investing in CRISPR: Which Gene Editing Stock to Buy?

We’ve talked before about gene editing and a technique called CRISPR or CRISPR Cas9 that allows us to start changing DNA such that we can do useful things like create nanobots or eradicate inherited diseases. A while back we highlighted 7 companies playing in the gene editing space and at the time we wrote that original […]

Gene Editing Company Editas Files for IPO

2016 hasn’t started out too well for equity investors, with the S&P 500 dropping -6% in the first week of 2016 trading alone. This doesn’t bode well for IPOs, especially for biotech IPOs, which were hot in 2015 but have been punished as of late. One of our most popular articles in the past few months has […]

7 Gene Editing Companies Investors Should Watch

A gene editing technology called CRISPR has been called “The Biggest Biotech Discovery of the Century” by the MIT Technology Review and Forbes magazine has said that this technology could change biotech forever. Some surprising news came out of China this week, when it was announced that Chinese scientists had utilized CRISPR to alter the DNA […]

CRISPR Genome Editing from Editas

Dr. George Church, is a Professor of Genetics at Harvard and widely considered to be a pioneer in synthetic biology. In previous articles, we have highlighted companies he is involved in including genome interpretation company Knome which he co-founded and Joule, a synthetic biology company producing diesel fuel and ethanol directly from sunlight, where he sits as […]